BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4840442)

  • 1. Thermal inactivation as a means of inhibiting the serum-associated deamination of 9-beta-D Arabinofuranosyladenine in tissue culture media.
    Schwartz PM; Shipman C; Carlson RH; Drach JC
    Antimicrob Agents Chemother; 1974 Mar; 5(3):337-43. PubMed ID: 4840442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 3. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
    Schwartz PM; Novack J; Shipman C; Drach JC
    Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
    Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL
    J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH; Shipman C; Drach JC
    Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB; Bailey EJ; Lerner AM
    J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 9-beta-D-arabinofuranosyladenine on polymer synthesis in a polyauxotrophic strain of Escherichia coli.
    Leung HB; Doering AM; Cohen SS
    J Bacteriol; 1966 Sep; 92(3):558-64. PubMed ID: 5332077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and pharmacology of apiose. 7. Susceptibility of some branched-chain sugar nucleosides to enzymatic deamination.
    Tronchet JM; Tronchet J; Graf R
    J Med Chem; 1974 Oct; 17(10):1055-6. PubMed ID: 4472858
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiproliferative effects of 9-beta-d-arabinofuranosyladenine in a mammalian cell line devoid of adenosine deaminase activity.
    Drach JC; Sandberg JN; Shipman C
    J Dent Res; 1977 Mar; 56(3):275-88. PubMed ID: 192768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
    Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
    Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the enzymatic deamination of cytosine arabinoside. II. Properties of the deaminase of human liver.
    Camiener GW
    Biochem Pharmacol; 1967 Sep; 16(9):1681-9. PubMed ID: 4964068
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of adenosine deaminase in Escherichia coli.
    Remy CN; Love SH
    J Bacteriol; 1968 Jul; 96(1):76-85. PubMed ID: 4874315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
    Cass CE; Tan TH; Selner M
    Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetic study of the deamination of some adenosine analogues. Substrate specificity of adenosine deaminase.
    York JL; LePage GA
    Can J Biochem; 1966 Mar; 44(3):331-7. PubMed ID: 5934241
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of exogenous purine bases and nucleosides by Salmonella typhimurium.
    Hoffmeyer J; Neuhard J
    J Bacteriol; 1971 Apr; 106(1):14-24. PubMed ID: 4928005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
    Shipman C; Smith SH; Carlson RH; Drach JC
    Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.